...
首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter A beta production
【24h】

Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter A beta production

机译:淀粉样前体蛋白相同密码子的常染色体显性阿尔茨海默氏病突变差异性地改变了Aβ的产生

获取原文
获取原文并翻译 | 示例

摘要

Autosomal-dominant Alzheimer's disease (ADAD) is a genetic disorder caused by mutations in Amyloid Precursor Protein (APP) or Presenilin (PSEN) genes. Studying the mechanisms underlying these mutations can provide insight into the pathways that lead to AD pathology. The majority of biochemical studies on APP mutations to-date have focused on comparing mechanisms between mutations at different codons. It has been assumed that amino acid position is a major determinant of protein dysfunction and clinical phenotype. However, the differential effect of mutations at the same codon has not been sufficiently addressed. In the present study we compared the effects of the aggressive ADAD-associated APP I716F mutation with I716V and I716T on APP processing in human neuroglioma and CHO-K1 cells. All APP I716 mutations increased the ratio of A beta 42/40 and changed the product line preference of gamma-secretase towards A beta 38 production. In addition, the APP I716F mutation impaired the epsilon-cleavage and the fourth cleavage of gamma-secretase and led to abnormal APP beta-CTF accumulation at the plasma membrane. Taken together, these data indicate that APP mutations at the same codon can induce diverse abnormalities in APP processing, some resembling PSEN1 mutations. These differential effects could explain the clinical differences observed among ADAD patients bearing different APP mutations at the same position.
机译:常染色体显性阿尔茨海默氏病(ADAD)是由淀粉样前体蛋白(APP)或早老素(PSEN)基因突变引起的遗传性疾病。研究这些突变的潜在机制可以提供导致AD病理的途径的见解。迄今为止,大多数有关APP突变的生化研究都集中在比较不同密码子突变之间的机制上。已经假定氨基酸位置是蛋白质功能障碍和临床表型的主要决定因素。但是,相同密码子突变的差异作用尚未得到充分解决。在本研究中,我们比较了侵​​略性ADAD相关APP I716F突变与I716V和I716T对人神经胶质瘤和CHO-K1细胞中APP处理的影响。所有APP I716突变均增加了A beta 42/40的比率,并改变了γ-分泌酶对A beta 38产生的产品线偏好。此外,APP I716F突变会损害ε裂解和γ分泌酶的第四次裂解,并导致质膜上异常的APPβ-CTF积聚。综上所述,这些数据表明,同一密码子上的APP突变可诱发APP加工过程中的多种异常,有些类似于PSEN1突变。这些差异效应可以解释在同一位置携带不同APP突变的ADAD患者之间观察到的临床差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号